HomeCTX • TSE
add
Crescita Therapeutics Inc
Previous close
$0.59
Day range
$0.61 - $0.69
Year range
$0.36 - $0.73
Market cap
10.27M CAD
Avg Volume
29.24K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
In the news
Financials
Income Statement
Revenue
Net income
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 5.00M | 8.56% |
Operating expense | 3.14M | 5.72% |
Net income | -626.00K | -129.30% |
Net profit margin | -12.53 | -111.30% |
Earnings per share | — | — |
EBITDA | -346.00K | -348.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.53M | -7.24% |
Total assets | 24.07M | -13.55% |
Total liabilities | 5.92M | -15.26% |
Total equity | 18.14M | — |
Shares outstanding | 19.44M | — |
Price to book | 0.63 | — |
Return on assets | -7.51% | — |
Return on capital | -9.28% | — |
Cash Flow
Net change in cash
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -626.00K | -129.30% |
Cash from operations | 378.00K | -82.26% |
Cash from investing | — | — |
Cash from financing | -236.00K | -138.38% |
Net change in cash | 146.00K | -92.83% |
Free cash flow | 449.88K | -77.60% |
About
Founded
2016
Website
Employees
78